Literature DB >> 2471221

Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding.

A E Kelley1, M Cador, L Stinus, M Le Moal.   

Abstract

The neuropeptides neurotensin, substance P, neurokinin-alpha (substance K), and met-enkephalin are present endogenously in the ventral tegmental area (VTA), site of the A10 dopaminergic (DA) cell bodies. In the present study these four peptides were injected bilaterally into the VTA in the rat, and the effects on operant behavior were assessed. Cannulae aimed at the VTA were implanted in four groups of animals, which had been trained to bar-press for food reward on a fixed-interval, 40-s schedule. A fifth group, in which the effects of systemically administered amphetamine were assessed, was also tested. Response rate across the interval was measured, and the index of quarter-life was taken as an indication of the temporal pattern of responding. In addition, a rate-dependency analysis was carried out for all data. Neurotensin (NT, 0.0175, 0.175, 0.5 micrograms in 1 microliter) dose-dependently decreased response rates without affecting quarter-life, and reduced the number of reinforcements obtained. Substance P (SP, 0.1, 1.0, 3.0 micrograms) did not affect responding, and neurokinin-alpha (NKA, 0.1, 1.0, 3.0 micrograms) induced a small increase in responding. Quarter-life was not affected by SP or NKA, but responding on the non-reinforced lever was significantly increased by both peptides. d-Ala-met-enkephalin (DALA, 0.01, 0.1, 1.0 micrograms) induced a dose-dependent increase in responding which was also rate-dependent, and reduced quarter-life. DALA effects were similar to the classic pattern of responding observed after systemic amphetamine. These results suggest that although all these peptides elicit behavioral activation and may affect DA neuronal activity, the behavioral responses can be differentiated with respect to operant behavior.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471221     DOI: 10.1007/bf00442258

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  A E Kelley; M Cador; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

3.  Neurotensin receptors are located on dopamine-containing neurones in rat midbrain.

Authors:  J M Palacios; M J Kuhar
Journal:  Nature       Date:  1981-12-10       Impact factor: 49.962

4.  A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immunocytochemistry.

Authors:  R P Johnson; M Sar; W E Stumpf
Journal:  Brain Res       Date:  1980-08-04       Impact factor: 3.252

5.  Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  M Cador; A E Kelley; M Le Moal; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Autoradiographic distribution of [3H]neurotensin receptors in rat brain: visualization by tritium-sensitive film.

Authors:  R Quirion; P Gaudreau; S St-Pierre; F Rioux; C B Pert
Journal:  Peptides       Date:  1982 Sep-Oct       Impact factor: 3.750

8.  Neurotensin depolarizes substantia nigra dopamine neurones.

Authors:  R D Pinnock
Journal:  Brain Res       Date:  1985-07-08       Impact factor: 3.252

9.  Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin.

Authors:  T C Napier; D A Gay; K L Hulebak; G R Breese
Journal:  Peptides       Date:  1985 Nov-Dec       Impact factor: 3.750

10.  Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones.

Authors:  A E Kelley; L Stinus; S D Iversen
Journal:  Neurosci Lett       Date:  1979-03       Impact factor: 3.046

View more
  14 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Neuropharmacology       Date:  2018-01-05       Impact factor: 5.250

3.  Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.

Authors:  F Scott Hall; Marjorie Centeno; Maria T G Perona; Jordan Adair; Paul R Dobner; George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

4.  Neurotensin Receptor-1 Identifies a Subset of Ventral Tegmental Dopamine Neurons that Coordinates Energy Balance.

Authors:  Hillary L Woodworth; Hannah M Batchelor; Bethany G Beekly; Raluca Bugescu; Juliette A Brown; Gizem Kurt; Patrick M Fuller; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

Review 5.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

6.  Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area.

Authors:  A E Kelley; J M Delfs
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.

Authors:  Mario E Alburges; Amanda J Hoonakker; Glen R Hanson
Journal:  Eur J Pharmacol       Date:  2007-07-24       Impact factor: 4.432

8.  Lateral Hypothalamic Neurotensin Neurons Orchestrate Dual Weight Loss Behaviors via Distinct Mechanisms.

Authors:  Hillary L Woodworth; Bethany G Beekly; Hannah M Batchelor; Raluca Bugescu; Patricia Perez-Bonilla; Laura E Schroeder; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

9.  Responses of limbic and extrapyramidal substance P systems to nicotine treatment.

Authors:  Mario E Alburges; Paul S Frankel; Amanda J Hoonakker; Glen R Hanson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-05       Impact factor: 4.530

10.  Opioid modulation of ventral pallidal afferents to ventral tegmental area neurons.

Authors:  Gregory O Hjelmstad; Yanfang Xia; Elyssa B Margolis; Howard L Fields
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.